Updated quality of life data from the phase 3b VENICE II trial: patients with relapsed or refractory chronic lymphocytic leukemia receiving venetoclax monotherapy
- Author(s)
- Cochrane, T; Enrico, A; Gomez-Almaguer, D; Hadjiev, E; Lech-Maranda, E; Masszi, T; Nikitin, E; Robak, T; Weinkove, R; Wu, SJ; Manzoor, BS; Busman, T; Pai, M; Komlosi, V; Anderson, MA;
- Details
- Publication Year 2024-11,Volume 65,Issue #11,Page 1743-1746
- Journal Title
- Leukemia & Lymphoma
- Publication Type
- Research article
- Publisher
- Taylor & Francis
- Department(s)
- Haematology
- Publisher's Version
- https://doi.org/10.1080/10428194.2023.2247511
- Open Access at Publisher's Site
https://doi.org/10.1080/10428194.2023.2247511- Terms of Use/Rights Notice
- Refer to copyright notice on published article.
Creation Date: 2024-12-10 02:53:52
Last Modified: 2024-12-10 02:54:10